SEC Form 4 · accession 0001823381-26-000014
Alamar Biosciences, Inc. · ALMR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John L. Brottem
Officer — General Counsel
Period of report
Sep 14, 2026
Accepted (ET)
Sep 16, 2026 · 4:20 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0002104204
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 14, 2026 | A | 29,000 | $0.00 | A | 29,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F2 | $27.99 | Sep 14, 2026 | A | 85,000 | A | — | Sep 13, 2036 | Common Stock | 85,000 | 85,000 | D |
Explanation of responses
- F1Represents a restricted stock unit ("RSU") award. One-quarter of the RSUs will vest on November 21, 2027 and the remainder of the RSUs will vest in twelve equal quarterly installments thereafter, subject to the reporting person's continuous service as of each such vesting date.
- F2One-quarter of the total shares subject to the option will vest on September 14, 2027 and the remainder of the shares subject to the grant will vest in 36 equal monthly installments thereafter, subject to the reporting person's continuous service as of each such vesting date.